Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis.

Ahmadzay ZF, Ørnbjerg LM, Østergaard M, Jensen KY, Jørgensen JB, Heberg J, Loft AG, Michelsen B, Jones GT, Hellamand P, Møller-Bisgaard S, Shoae Kazemi M, Karimi Reikandeh P, Závada J, Horák P, Bernardes M, Vieira-Sousa E, Castrejón I, Otero-Varela L, Codreanu C, Kuusalo L, Rantalaiho V, Regierer AC, Reich A, Möller B, Micheroli R, Mielnik P, Provan SA, Lass K, Vorobjov S, Rotar Z, Pirkmajer KP, Iannone F, Conti F, Gudbjornsson B, Di Giuseppe D, van de Sande M, Macfarlane GJ, Yarkan-Tuğsal H, Glintborg B, Hetland ML

Open source

DOI
10.1136/rmdopen-2025-006477
Published
2026 May 7
Container
RMD open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/rmdopen-2025-006477,
  title = {Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis.},
  author = {Ahmadzay ZF and Ørnbjerg LM and Østergaard M and Jensen KY and Jørgensen JB and Heberg J and Loft AG and Michelsen B and Jones GT and Hellamand P and Møller-Bisgaard S and Shoae Kazemi M and Karimi Reikandeh P and Závada J and Horák P and Bernardes M and Vieira-Sousa E and Castrejón I and Otero-Varela L and Codreanu C and Kuusalo L and Rantalaiho V and Regierer AC and Reich A and Möller B and Micheroli R and Mielnik P and Provan SA and Lass K and Vorobjov S and Rotar Z and Pirkmajer KP and Iannone F and Conti F and Gudbjornsson B and Di Giuseppe D and van de Sande M and Macfarlane GJ and Yarkan-Tuğsal H and Glintborg B and Hetland ML},
  year = {2026},
  journal = {RMD open},
  doi = {10.1136/rmdopen-2025-006477},
  url = {https://doi.org/10.1136/rmdopen-2025-006477}
}

RIS

TY  - JOUR
TI  - Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis.
AU  - Ahmadzay ZF
AU  - Ørnbjerg LM
AU  - Østergaard M
AU  - Jensen KY
AU  - Jørgensen JB
AU  - Heberg J
AU  - Loft AG
AU  - Michelsen B
AU  - Jones GT
AU  - Hellamand P
AU  - Møller-Bisgaard S
AU  - Shoae Kazemi M
AU  - Karimi Reikandeh P
AU  - Závada J
AU  - Horák P
AU  - Bernardes M
AU  - Vieira-Sousa E
AU  - Castrejón I
AU  - Otero-Varela L
AU  - Codreanu C
AU  - Kuusalo L
AU  - Rantalaiho V
AU  - Regierer AC
AU  - Reich A
AU  - Möller B
AU  - Micheroli R
AU  - Mielnik P
AU  - Provan SA
AU  - Lass K
AU  - Vorobjov S
AU  - Rotar Z
AU  - Pirkmajer KP
AU  - Iannone F
AU  - Conti F
AU  - Gudbjornsson B
AU  - Di Giuseppe D
AU  - van de Sande M
AU  - Macfarlane GJ
AU  - Yarkan-Tuğsal H
AU  - Glintborg B
AU  - Hetland ML
PY  - 2026
JO  - RMD open
DO  - 10.1136/rmdopen-2025-006477
UR  - https://doi.org/10.1136/rmdopen-2025-006477
ER  -

APA

ZF, A., LM, Ø., M, Ø., KY, J., JB, J., J, H., AG, L., B, M., GT, J., P, H., S, M., M, S. K., P, K. R., J, Z., P, H., M, B., E, V., I, C., L, O., C, C., L, K., V, R., AC, R., A, R., B, M., R, M., P, M., SA, P., K, L., S, V., Z, R., KP, P., F, I., F, C., B, G., D, D. G., M, V. D. S., GJ, M., H, Y., B, G., & ML, H. (2026). Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis.. RMD open. https://doi.org/10.1136/rmdopen-2025-006477

Source records